Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index

References

• Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–2749. Jun
   PubMed Web of Science ®Google Scholar
• Hahn S, van Halteren WB, Kimming R, et al. Diagnostik des polycystischen ovarsyndroms/diagnostic procedures in polycystic ovary syndrome. Laborator Medizin. 2003;27(1/2):53–59. Feb 1
   Google Scholar
• Fauser BCJM, Tarlatzis BC, Rebar RW, et al . Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38.e25. Jan
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520.
   PubMed Web of Science ®Google Scholar
• Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.
   PubMed Web of Science ®Google Scholar
• Legro RS, Arslanian SA, Ehrmann DA, Endocrine Society, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–4592. Dec
   PubMed Web of Science ®Google Scholar
• Conway G, Dewailly D, Diamanti-Kandarakis E, ESE PCOS Special Interest Group, et al. The polycystic ovary syndrome: a position statement from the european society of endocrinology. Eur J Endocrinol. 2014;171(4):P1–29. Oct
   PubMed Web of Science ®Google Scholar
• Genazzani AD. Inositol as putative integrative treatment for PCOS. Reprod Biomed Online. 2016; Dec33(6):770–780.
   PubMed Web of Science ®Google Scholar
• Genazzani AD. Expert’s opinion: integrative treatment with inositols and lipoic acid for insulin resistance of PCOS. Gynecol Reproduct Endocrinol Metabol. 2020;1:146–157.
   Google Scholar
• Porcaro G GG. Polycystic ovary syndrome: Features, diagnostic criteria and treatments. Endocrinol Metabol Syndrome. 2014;3(3).
   Google Scholar
• Thomas RM, Nechamen CA, Mazurkiewicz JE, et al. The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization. Endocrinology. 2011;152(4):1691–1701. Apr
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Santagni S, Rattighieri E, et al. Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. Gynecol Endocrinol. 2014;30(6):438–443. Jun
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Prati A, Santagni S, et al. Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecol Endocrinol. 2012;28(12):969–973. Dec
   PubMed Web of Science ®Google Scholar
• Unfer V, Carlomagno G, Dante G, et al. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28(7):509–515. Jul
   PubMed Web of Science ®Google Scholar
• Dinicola S, Chiu TTY, Unfer V, et al. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. J Clin Pharmacol. 2014;54(10):1079–1092. Oct
   PubMed Web of Science ®Google Scholar
• Masharani U, Gjerde C, Evans JL, et al. Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome. J Diabetes Sci Technol. 2010 Mar 1;4(2):359–364.
   PubMedGoogle Scholar
• Musi N, Hirshman MF, Nygren J, et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes. 2002;51(7):2074–2081. Jul
   PubMed Web of Science ®Google Scholar
• Scaramuzza A, Giani E, Redaelli F, et al. Alpha-Lipoic acid and antioxidant diet help to improve endothelial dysfunction in adolescents with type 1 diabetes: a pilot trial. J Diabetes Res. 2015;2015:474561.
   PubMed Web of Science ®Google Scholar
• Padmalayam I, Hasham S, Saxena U, et al. Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance. Diabetes. 2009;58(3):600–608. Mar
   PubMed Web of Science ®Google Scholar
• Morikawa T, Yasuno R, Wada H. Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett. 2001;498(1):16–21.
   PubMed Web of Science ®Google Scholar
• Madeira IR, Carvalho CNM, Gazolla FM, et al. [Cut-off point for homeostatic model assessment for insulin resistance (HOMA-IR) index established from receiver operating characteristic (ROC) curve in the detection of metabolic syndrome in overweight pre-pubertal children]. Arq Bras Endocrinol Metabol. 2008;52(9):1466–1473. Dec
   PubMedGoogle Scholar
• Genazzani AD, Petraglia F, Fabbri G, et al. Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss. Fertil Steril. 1990;54(2):222–226. Aug
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Petraglia F, Pianazzi F, et al. The concomitant release of androstenedione with cortisol and luteinizing hormone pulsatile releases distinguishes adrenal from ovarian hyperandrogenism. Gynecol Endocrinol. 1993;7(1):33–41. Mar
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Prati A, Simoncini T, et al. Modulatory role of D-chiro-inositol and alpha lipoic acid combination on hormonal and metabolic parameters of overweight/obese PCOS patients. Eur Gynecol Obstetric. 2019;1:29–33.
   Google Scholar
• O’Reilly MW, Taylor AE, Crabtree NJ, et al. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab. 2014;99(3):1027–1036.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Podfigurna A, Szeliga A, et al. Kisspeptin in female reproduction: from physiology to pathophysiology. Gynecol Reproduct Endocrinol Metabol. 2021;2:148–155.
   Google Scholar
• Genazzani AD, Shefer K, Della Casa D, et al. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. J Endocrinol Invest. 2018;41(5):583–590.
   PubMed Web of Science ®Google Scholar
• Genazzani A. Inositols: reflections on how to choose the appropriate one for PCOS. Gynecol Endocrinol. 2020;36(12):1045–1046.
   PubMed Web of Science ®Google Scholar
• Macut D, Božić-Antić I, Bjekić-Macut J, et al. Management of endocrine disease: polycystic ovary syndrome and nonalcoholic fatty liver disease. Eur J Endocrinol. 2017;177(3):R145–58.
   PubMedGoogle Scholar
• Bae JC, Rhee EJ, Lee WY, et al. Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. Diabetes Care. 2011;34(3):727–729. Mar
   PubMed Web of Science ®Google Scholar
• Finucane FM, Sharp SJ, Hatunic M, et al. Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals. Diabetol Metab Syndr. 2014;6(1):43.
   PubMedGoogle Scholar
• Leissring MA, González-Casimiro CM, Merino B, et al. Targeting insulin-degrading enzyme in insulin clearance. IJMS. 2021;22(5):2235.
   Google Scholar
• Steiner DF, Cunningham D, Spigelman L, et al. Insulin biosynthesis: evidence for a precursor. Science. 1967;157(3789):697–700.
   PubMed Web of Science ®Google Scholar
• Faber OK, Hagen C, Binder C, et al. Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest. 1978;62(1):197–203.
   PubMed Web of Science ®Google Scholar
• Polonsky K, Jaspan J, Pugh W, et al. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest. 1983;72(3):1114–1123. Sep
   PubMed Web of Science ®Google Scholar
• Tura A, Ludvik B, Nolan JJ, et al. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001;281(5):E966–974. Nov
   PubMed Web of Science ®Google Scholar
• Caumo A, Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab. 2004;287(3):E371–385.
   PubMed Web of Science ®Google Scholar
• Grodsky GM. A new phase of insulin secretion. How will it contribute to our understanding of beta-cell function? Diabetes. 1989;38(6):673–678.
   PubMed Web of Science ®Google Scholar
• Daniel S, Noda M, Straub SG, et al. Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. Diabetes. 1999;48(9):1686–1690. Sep
   PubMed Web of Science ®Google Scholar
• Fosam A, Sikder S, Abel BS, et al. Reduced insulin clearance and Insulin-Degrading enzyme activity contribute to hyperinsulinemia in african americans. J Clin Endocrinol Metab. 2020;105(4):dgaa070.
   PubMed Web of Science ®Google Scholar